Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emi Tanaka

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Cancers|August 28, 2025
Prognostic Impact of Gastrointestinal Immune-Related Adverse Events Depends on Nutritional Status in Cancer Patients Treated with Immune Checkpoint InhibitorsShoichiro Hirata, Yoshiyasu Kono, Emi Tanaka, et al.
Scientific Reports|March 14, 2020
Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safetyMasahiro Tsuji, Mariko Sawada, Shinichi Watabe, et al.
Clinical Oral Investigations|June 29, 2020
Analysis of oral risk factors for ventilator-associated pneumonia in critically ill patientsAdemar Takahama, Vitoria Iaros de Sousa, Elisa Emi Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 9, 2026
Borderline Resectable Classification Identifies Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab and BevacizumabYasuto Takeuchi, Masahiko Sue, Nozomi Miyake, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 22, 2020
Efficacy and Safety of the Modified EPOCH Regimen (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Adult T-cell Leukemia/Lymphoma: A Multicenter Retrospective StudyYasuhiro Tsukamoto, Junichi Kiyasu, Ilseung Choi, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Cancers|August 28, 2025
Prognostic Impact of Gastrointestinal Immune-Related Adverse Events Depends on Nutritional Status in Cancer Patients Treated with Immune Checkpoint InhibitorsShoichiro Hirata, Yoshiyasu Kono, Emi Tanaka, et al.
Scientific Reports|March 14, 2020
Autologous cord blood cell therapy for neonatal hypoxic-ischaemic encephalopathy: a pilot study for feasibility and safetyMasahiro Tsuji, Mariko Sawada, Shinichi Watabe, et al.
Clinical Oral Investigations|June 29, 2020
Analysis of oral risk factors for ventilator-associated pneumonia in critically ill patientsAdemar Takahama, Vitoria Iaros de Sousa, Elisa Emi Tanaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 9, 2026
Borderline Resectable Classification Identifies Candidates for Conversion Therapy in Unresectable Hepatocellular Carcinoma Treated With Atezolizumab and BevacizumabYasuto Takeuchi, Masahiko Sue, Nozomi Miyake, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 22, 2020
Efficacy and Safety of the Modified EPOCH Regimen (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Adult T-cell Leukemia/Lymphoma: A Multicenter Retrospective StudyYasuhiro Tsukamoto, Junichi Kiyasu, Ilseung Choi, et al.
Pageof 9